Headlands Technologies LLC raised its holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) by 31.3% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 9,037 shares of the biopharmaceutical company’s stock after acquiring an additional 2,153 shares during the quarter. Headlands Technologies LLC’s holdings […]
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) – Analysts at Leerink Partnrs issued their Q3 2024 earnings per share (EPS) estimates for shares of Agios Pharmaceuticals in a research report issued to clients and investors on Monday, February 5th. Leerink Partnrs analyst A. Berens expects that the biopharmaceutical company will post earnings per share of […]
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) insider James William Burns sold 1,708 shares of Agios Pharmaceuticals stock in a transaction dated Wednesday, January 24th. The stock was sold at an average price of $21.64, for a total value of $36,961.12. Following the completion of the sale, the insider now directly owns 30,378 shares […]
Agios Pharmaceuticals, Inc (NASDAQ:AGIO) Insider Sells $26,737 37 in Stock kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) had its target price cut by JPMorgan Chase & Co. from $33.00 to $32.00 in a research report sent to investors on Monday morning, Benzinga reports. They currently have a neutral rating on the biopharmaceutical company’s stock. Several other analysts also recently issued reports on AGIO. StockNews.com downgraded Agios […]